![Fred Garzoni](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenienza dei contatti di primo grado di Fred Garzoni
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Imophoron Ltd.
![]() Imophoron Ltd. BiotechnologyHealth Technology Imophoron Ltd. is an American company that specializes in cutting-edge vaccine development. The company's scientific advisory board consists of world-leading experts in vaccine technology and infectious diseases. The company is constantly exploring new and innovative ways to combat infection using the latest techniques from science and technology. More information about the company can be found on their website at www.imophoron.com. The company was founded by Fred Garzoni and Richard Edward Bungay has been the CEO of the company since 2022.
3
| Holding Company | Biotechnology | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Fred Garzoni tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
NICOX SA | Pharmaceuticals: Major | Corporate Officer/Principal | |
The University of Liverpool
![]() The University of Liverpool Other Consumer ServicesConsumer Services The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom. | College/University | Undergraduate Degree | |
University of Bristol | College/University | Doctorate Degree | |
Chroma Therapeutics Ltd.
![]() Chroma Therapeutics Ltd. BiotechnologyHealth Technology Chroma Therapeutics Ltd. engages in the discovery and development of therapies for the treatment of cancer and inflammation. It focuses on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. The firm uses chromatin biology, drug accumulation approaches to discover and develop cancer, inflammation treatments and small molecule drugs. The company was founded by David Allis, Alan Hornsby Davidson, Alan Hastings Drummond, Anthony Kouzarides and Paul Workman in September 2001 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member | |
Trophos SA
![]() Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Pharmaceuticals: Major | Chief Executive Officer | |
The University of Nottingham | College/University | Undergraduate Degree | |
VERONA PHARMA PLC | Pharmaceuticals: Major | Director of Finance/CFO | |
France Biotech Association
![]() France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Director/Board Member | |
Bausch & Lomb (Australia) Pty Ltd.
![]() Bausch & Lomb (Australia) Pty Ltd. Pharmaceuticals: MajorHealth Technology Bausch & Lomb Australia Pty Ltd. manufactures and distributes prescription medicines. It offers consumer healthcare, prescription, aesthetic skin and eyecare. The company was founded in 2006 and is headquartered in Chatswood, Australia. | Pharmaceuticals: Major | Corporate Officer/Principal | |
TXCELL | Miscellaneous Commercial Services | Chief Executive Officer | |
DIUL GROUP | Pharmaceuticals: Major | Chief Executive Officer | |
Glaxo Wellcome Immobilière de Recherche SA
![]() Glaxo Wellcome Immobilière de Recherche SA Real Estate DevelopmentFinance Glaxo Wellcome Immobilière de Recherche SA provides real estate services. The company was founded in 1992 and is headquartered in Marly-le-Roi, France. | Real Estate Development | Corporate Officer/Principal | |
CANTARGIA AB | Pharmaceuticals: Major | Director/Board Member | |
Macrotarg Ltd.
![]() Macrotarg Ltd. BiotechnologyHealth Technology Macrotarg Ltd. is a biotechnology research and British experimental development company founded in 2007. The private company is based in Winnersh, UK. | Biotechnology | Director/Board Member | |
Nasdaq Corporate Solutions International Ltd.
![]() Nasdaq Corporate Solutions International Ltd. Packaged SoftwareTechnology Services Nasdaq Corporate Solutions International Ltd. develops and manages software for corporate communications and reputation management solutions. The company was founded in and is headquartered in London, the United Kingdom. | Packaged Software | Director/Board Member | |
CIRCIO HOLDING ASA | Biotechnology | Chairman | |
Theralpha | Director/Board Member | ||
CAMBRIDGE COGNITION HOLDINGS PLC | Packaged Software | Director/Board Member | |
Loxbridge Research LLP
![]() Loxbridge Research LLP Financial ConglomeratesFinance Loxbridge Research LLP operates as an investment and project management company. It specializes in startup, early stage, and later stage investments in growth stage companies. The firm supports scientists and focuses on sectors like science, medicine and healthcare technology particularly biotech, med-tech, noval therapeutic, diagnostics, cancer, infectious diseases, neurodegeneration, imaging hardware and software, and enabling devices. The company was founded by Charles Roberts in 2008 and is headquartered in London, the United Kingdom. | Financial Conglomerates | Director/Board Member | |
Agalimmune Ltd.
![]() Agalimmune Ltd. Pharmaceuticals: MajorHealth Technology Part of BioLineRx Ltd., Agalimmune Ltd. is a British company that develops anti-cancer immunotherapy technology. The company is based in London, UK. The company was founded by Charles Campbell Roberts and Graham Griffiths. The CEO is Mike Westby. Agalimmune was acquired by BioLineRx Ltd. on March 23, 2017 for $6.05 million. | Pharmaceuticals: Major | Director/Board Member | |
MEREO BIOPHARMA GROUP PLC | Biotechnology | Director of Finance/CFO | |
Diurnal Ltd.
![]() Diurnal Ltd. Pharmaceuticals: MajorHealth Technology Part of Neurocrine Biosciences, Inc., Diurnal Ltd. is a European, British UK-headquartered specialty pharmaceutical company founded in 2004. The company is based in Cardiff, UK. The company is dedicated to developing lifelong treatments for rare and chronic endocrine conditions. | Pharmaceuticals: Major | Director/Board Member | |
Resolys Bio, Inc.
![]() Resolys Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Resolys Bio, Inc. operates as a pharmaceutical company. The firm develops OSLO and MCC for the treatment of certain forms of traumatic brain injury and chronic painful tissue disorders. The company is headquartered in Delanson, NY. | Miscellaneous Commercial Services | Director/Board Member | |
Ziylo Ltd.
![]() Ziylo Ltd. Pharmaceuticals: MajorHealth Technology Ziylo Ltd. engages in manufacturing diabetes medicines. The company was founded on May 14, 2014 and is headquartered in Bristol, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer | |
Cytoseek Ltd.
![]() Cytoseek Ltd. Miscellaneous Commercial ServicesCommercial Services Cytoseek Ltd. provides cell membrane augmentation technology for enhancement of cell therapies for cancer, heart disease, osteoarthritis, and diabetic wound healing. It enables new functionalities to cell therapies including tissue specific targeting and enhanced cell survivability. The company was founded by Adam Willis Perriman on November 22, 2017 and is headquartered in Bristol, the United Kingdom. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Pepgen Ltd.
![]() Pepgen Ltd. Packaged SoftwareTechnology Services Pepgen Ltd. engages in research and experimental development on biotechnology. The company was founded on January 25, 2018 and is headquartered in Oxford, the United Kingdom. | Packaged Software | Chairman | |
Treehill Partners, LLC | Corporate Officer/Principal | ||
Forefront RF Ltd
![]() Forefront RF Ltd Electronic Production EquipmentElectronic Technology Forefront RF Ltd engages in the manufacture of electronic components. The company was founded on January 20, 2020 and is headquartered in Bristol, the United Kingdom. | Electronic Production Equipment | Director/Board Member | |
Science Creates Ventures
![]() Science Creates Ventures Investment ManagersFinance Science Creates Ventures LLP (Science Creates Ventures) is a venture capital firm founded in 2020 by Harry Destecroix and Jonathan Craton. The firm is headquartered in Bristol, United Kingdom. | Investment Managers | Founder | |
Carbometrics Ltd.
![]() Carbometrics Ltd. BiotechnologyHealth Technology Carbometrics Ltd. is a British company that specializes in developing a new glucose sensor chemistry using their proprietary biomimetic glucose binding molecules (GBM). The company is based in Bristol, UK. The company's mission is to help people with diabetes live more normal and longer lives by creating market-leading continuous glucose monitors (CGM). Carbometrics was founded in 2018 by Keith Joseph MacDonald, Anthony Davis, Harry Destecroix, and Andy Chapman. Andy Chapman has been the CEO since 2018. | Biotechnology | Founder | |
Monument Therapeutics Ltd.
![]() Monument Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Monument Therapeutics Ltd. is a British UK-based biotechnology company that focuses on bringing precision medicine to neuroscience drug development. The company is based in Bottisham, UK, and was founded in 2019. The company was formed as a spin-out from Cognition and has a mission to use precision medicine to develop therapeutic products for patients with substantial central nervous system indications and significant unmet medical needs. Monument Tx has a well-balanced pipeline that includes two lead programs, and proprietary biomarkers developed by the team allow for precise selection of patients most likely to benefit from treatment. The therapeutic products under development are novel formulations utilizing well-characterized technology. Jenny Barnett has been the CEO of the company since 2019. | Pharmaceuticals: Major | Director/Board Member | |
Acu-Flow Ltd.
![]() Acu-Flow Ltd. Medical SpecialtiesHealth Technology Acu-Flow Ltd. is a British company founded in 2019 that specializes in developing the next generation of nebulizers for respiratory drug delivery. The company is based in Glasgow, UK. The company's flagship product, Nebu~Flow, is designed to enable the delivery of life-changing treatments. | Medical Specialties | Director/Board Member | |
Scarlet Therapeutics Ltd.
![]() Scarlet Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Scarlet Therapeutics Ltd. is a company located in the UK that specializes in developing red blood cell-based therapeutics to potentially treat a wide range of diseases. The British company is considered a leader in this field and are currently working on a pioneering platform to generate novel TRBCs. | Miscellaneous Commercial Services | Director/Board Member | |
Portal Biotech Ltd.
![]() Portal Biotech Ltd. Miscellaneous Commercial ServicesCommercial Services Portal Biotech Ltd. is a British biotechnology company founded in 2021 that engages in research and experimental development in the field of biotechnology. The company is based in Abingdon, UK. | Miscellaneous Commercial Services | Director/Board Member | |
Orphan Europe SARL
![]() Orphan Europe SARL Pharmaceuticals: MajorHealth Technology Orphan Europe SARL develops and distributes orphan drugs for the treatment of rare diseases. The firm's products include Normosang, Cystagon, Pedea, Carbaglu, Wilzin, Cystadane. The company was founded by William Gunnarsson in 1990 and is headquartered in Puteaux, France. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistiche
Distribuzione geografica
Regno Unito | 27 |
Francia | 9 |
Stati Uniti | 3 |
Australia | 2 |
Paesi Bassi | 2 |
Settori
Health Technology | 23 |
Commercial Services | 7 |
Consumer Services | 4 |
Finance | 4 |
Technology Services | 4 |
Posizioni
Director/Board Member | 24 |
Chief Executive Officer | 8 |
Corporate Officer/Principal | 7 |
Director of Finance/CFO | 6 |
Chairman | 4 |
Contatti più connessi
Insiders | |
---|---|
Damian Marron | 21 |
Richard Bungay | 14 |
Harry Destecroix | 11 |
- Borsa valori
- Insiders
- Fred Garzoni
- Connessioni Società